By Phil Boeyen, ShareChat Business News Editor
|
Friday 24th August 2001 |
Text too small? |
Net earnings for the year ended June were $5.18 million, up from last year's $4.24 million result. Sales rose $26 million to $106.8 million.
The company says it produced record earnings before interest and tax of $9 million, including a 50% share of Health Support Ltd earnings which returned a $1.252 million pre tax-profit for our half share.
"Other highlights have been the positive cash flow, in part from premises rationalisation which has allowed repayment of debt totalling $4.2 million, and the strong growth in earnings per share," the company says.
Ebos says it has been focused on integrating the Medic acquisition before proceeding with growth initiatives.
"With this project now completed we are evaluating a number of exciting new growth prospects - both in Australia and New Zealand."
A final dividend of 7.5 cents per share has been declared to bring the year's total to 14 cents, 1 cent higher than last year's payout.
No comments yet
Ebos still hungry for acquisitions after $1.1 bln Symbion deal, Waller says
Ebos meets prospectus forecast with 5.5 percent gain in FY profit
Ebos shareholders approve $1.1 billion purchase of Symbion
Ebos grabs scale with $1.1 bln purchase of Aussie pharma distributor Symbion
Ebos kicks tyres on potential acquisitions
Ebos lifts profit by 19%, targets growth in animal health
Ebos funding line smaller than previously flagged at $135 mln
Ebos Group
Ebos backs off British purchase, evaluates "significant" Australasian asset
Ebos reports higher profit, looks for acquisitions
